Literature DB >> 15947083

Natalizumab and progressive multifocal leukoencephalopathy.

Burt Adelman, Alfred Sandrock, Michael A Panzara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15947083     DOI： 10.1056/NEJMc055235

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis.

Authors:  Azza Ismail; Julie Kemp; Basil Sharrack
Journal:  J Neurol       Date:  2009-07-16       Impact factor: 4.849

Review 2.  Update on the management of Crohn's disease.

Authors:  Anna M Buchner; Wojciech Blonski; Gary R Lichtenstein
Journal:  Curr Gastroenterol Rep       Date:  2011-10

Review 3.  Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis.

Authors:  Hans-Peter Hartung; Bernd C Kieseier; Bernhard Hemmer
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 4.  Emerging pharmacologic therapies for primary sclerosing cholangitis.

Authors:  Angela C Cheung; Konstantinos N Lazaridis; Nicholas F LaRusso; Gregory J Gores
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

Review 5.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 6.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 7.  Update on PML: lessons from the HIV uninfected and new insights in pathogenesis and treatment.

Authors:  Elizabeth A Hartman; DeRen Huang
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

Review 8.  Developing therapeutics for the treatment of multiple sclerosis.

Authors:  David J Virley
Journal:  NeuroRx       Date:  2005-10

9.  Natalizumab in the treatment of Crohn's disease.

Authors:  Danila Guagnozzi; Renzo Caprilli
Journal:  Biologics       Date:  2008-06

10.  Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy.

Authors:  Tarek A Yousry; Eugene O Major; Caroline Ryschkewitsch; Gary Fahle; Steven Fischer; Jean Hou; Blanche Curfman; Katherine Miszkiel; Nicole Mueller-Lenke; Esther Sanchez; Frederik Barkhof; Ernst-Wilhelm Radue; Hans R Jäger; David B Clifford
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.